We serve Chemical Name:tert-butyl N-naphthalen-2-ylsulfonylcarbamate CAS:461441-06-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:tert-butyl N-naphthalen-2-ylsulfonylcarbamate
CAS.NO:461441-06-5
Synonyms:tert-butyl 2-naphthalenesulfonylcarbamate;N-Boc-2-naphthalenesulfonamide;N-tert-Butyl-2-naphthalenesulfonylcarbamate
Molecular Formula:C15H17NO4S
Molecular Weight:307.36500
HS Code:2935009090
Physical and Chemical Properties:
Melting point:164-168ºC (dec.)(lit.)
Boiling point:N/A
Density:1.261g/cm3
Index of Refraction:1.586
PSA:80.85000
Exact Mass:307.08800
LogP:4.52490
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2811 6.1/PG 3
Packing Group:
Contact us for information like tert-butyl 2-naphthalenesulfonylcarbamate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-tert-Butyl-2-naphthalenesulfonylcarbamate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-tert-Butyl-2-naphthalenesulfonylcarbamate Use and application,tert-butyl 2-naphthalenesulfonylcarbamate technical grade,usp/ep/jp grade.
Related News: After testing, our quality assurance staff confirms that everything has been performed correctly in accordance with GMP from manufacturing of API to quality testing. tert-butyl N-naphthalen-2-ylsulfonylcarbamate manufacturer Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management, Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said. tert-butyl N-naphthalen-2-ylsulfonylcarbamate supplier A week before Eli Lilly (LLY.N) disclosed to regulators that the U.S. Justice Department was investigating its New Jersey factory, the drugmaker told employees that its own inquiry, led by an outside law firm, found no evidence of wrongdoing there, according to a company memo reviewed by Reuters. tert-butyl N-naphthalen-2-ylsulfonylcarbamate vendor The Darzalex-Rd regimen got its FDA go-ahead in transplant-ineligible patients in 2019 based on data from the same phase 3 MAIA trial showing it could pare down the risk of disease progression or death by 44% after a median follow-up of 28 months. Now, after 56.2 months of follow-up, over half of Darzalex patients were still alive without their disease worsening, a showing that’s again “unprecedented” for a front-line myeloma treatment, Tendler said. tert-butyl N-naphthalen-2-ylsulfonylcarbamate factory After testing, our quality assurance staff confirms that everything has been performed correctly in accordance with GMP from manufacturing of API to quality testing.
